Clinical trial

Carnitine Levels and Carnitine Supplementation in Type I Diabetes

NCT00351234 · Children's Mercy Hospital Kansas City, Other · Completed

Key facts

NCT number NCT00351234
Title Carnitine Levels and Carnitine Supplementation in Type I Diabetes
Official title Correlation Between Carnitine Deficiency and Hypoglycemic Events in Type I Diabetes; Effects of Carnitine Supplementation on Hypoglycemic Events in Type I Diabetes
Lead sponsor Children's Mercy Hospital Kansas City, Other
Collaborators Leadiant Biosciences, Inc. Industry Minimed Pharmaceuticals Pharmacia/Upjohn Career Development Award
Status Completed
Study type Observational
Conditions Diabetes Mellitus, Type I, Hypoglycemia
Intervention type Drug
Interventions Carnitine (drug)
Enrollment 200
Start date Oct 1, 2004
Completion Apr 1, 2007
First posted Jul 12, 2006
Last update posted Feb 28, 2012
Countries United States

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies